Skip to content

Neuroimaging and humoral factors study of cognitive impairment after aneurysmal subarachnoid hemorrhage

Neuroimaging and humoral factors study of cognitive impairment after aneurysmal subarachnoid hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028096
Enrollment
Unknown
Registered
2019-12-11
Start date
2019-12-04
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aneurysmal subarachnoid hemorrhage

Interventions

aneurysmal subarachnoid hemorrhage group:None
unruptured aneurysm group:None

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Subjects in the NC group: (1) Right-handed; (2) Patients with unruptured intracranial aneurysms on imaging examination; (3) No neurological, mental illness, no drug abuse or relying on, and no head injury that caused cognitive dysfunction; (4) No abnormalities were observed with conventional brain MRI; (5) Han nationality; (6) Have the ability to complete cognitive function assessment and cooperate with the acquisition of multimodal MRI data, Once every 3 months, 3 consecutive times; (7) Medical history includes negative current medical history, past history, family history, etc. And there are no positive findings that can cause cognitive impairment in the auxiliary examination data such as previous neuroimaging; aSAH subjects are included in the group: (1) Right-handed; (2) Patients with Hunt-Hess grade I-IV aSAH; (3) No history of neurological, psychiatric or drug abuse or dependence, and no head injury leading to cognitive dysfunction in the first 6 months; (4) Conventional brain MRI No abnormalities were observed; (5) Han nationality; (6) Cognitive function assessment can be completed, and multimodal MRI data can be collected, once every 3 months for 3 consecutive times.

Exclusion criteria

Exclusion criteria: Exclusion conditions for subjects in the NC group: (1) There are contraindications in claustrophobia that cannot be examined by MRI, including metal dentures, etc .; (2) Left-handed or double-handed. aSAH exclusion conditions (1) Cognitive impairment caused by severe depression (2) Delirium acute encephalopathy syndrome; (3) Other diseases of the nervous system that can cause cognitive dysfunction (such as brain tumors, Parkinson's disease, encephalitis, Epilepsy, etc.); (4) The aSAH was caused by brain trauma; (5) Other systemic diseases that can cause cognitive damage, such as abnormal thyroid function, severe anemia, syphilis, HIV, etc .; (6) People with a history of mental illness or congenital Those who are stunted; (7) People with severe hearing and vision impairments who cannot cooperate with the examination; (8) Left-handed or double-handed people; (9) Cryophobia, which contains metal that cannot be examined by MRI, including metal denture Such as MRI contraindications, those who cannot complete MRI.

Design outcomes

Primary

MeasureTime frame
total-Tau protein;phosphorylated tau on amino acid 181;amyloid beta 1-40;amyloid beta 1-42;Urine aSAH7c-NTP;functional MRI;neuropsychological test scale;event related potential;

Secondary

MeasureTime frame
aneurysm size;aneurysm site;Hunt-Hess grading;

Countries

China

Contacts

Public ContactHongqi Zhang

Xuanwu Hospital, Capital Medical University

xwzhanghq@163.com+86 13601374152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026